José Antonio
Arias Navalón
Investigador hasta 2022
Fundación Hospital Alcorcón
Alcorcón, EspañaPublicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (9)
2023
-
Real-world experience of OnabotulinumtoxinA treatment in female patients with chronic migraine: a qualitative study using in-depth interviews
Annals of Medicine, Vol. 55, Núm. 2
2022
-
Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability
Respiration, Vol. 101, Núm. 2, pp. 132-141
-
Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a case–control study
Journal of Human Hypertension
2021
-
Anxiety, depression and poor sleep quality as long-term post-COVID sequelae in previously hospitalized patients: A multicenter study
Journal of Infection
-
Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study
Journal of Infection
-
Similar prevalence of long-term post-COVID symptoms in patients with asthma: A case-control study
Journal of Infection
2020
-
Perinuclear lamin a and nucleoplasmic lamin B2 characterize two types of hippocampal neurons through Alzheimer’s disease progression
International Journal of Molecular Sciences, Vol. 21, Núm. 5
2016
-
Botulinum neurotoxin type-A for the treatment of atypical odontalgia
Pain Medicine (United States), Vol. 17, Núm. 9, pp. 1717-1721
2010
-
Pressure pain sensitivity of the scalp in patients with nummular headache: A cartographic study
Cephalalgia, Vol. 30, Núm. 2, pp. 200-206